Aerosolized amikacin for treatment of pulmonary Mycobacterium avium infections: an observational case series.
about
US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosisAntibiotic management of lung infections in cystic fibrosis. II. Nontuberculous mycobacteria, anaerobic bacteria, and fungiManagement of pulmonary nontuberculous mycobacterial disease.Progressive dyspnoea following the treatment of Mycobacterium abscessus infection in an individual with relapsing granulamatosis with polyangitis (Wegener's), complicated by hearing loss requiring cochlear implantationInhaled therapeutics for prevention and treatment of pneumoniaClinical efficacy and safety of multidrug therapy including thrice weekly intravenous amikacin administration for Mycobacterium abscessus pulmonary disease in outpatient settings: a case series.The Challenge of Pulmonary Nontuberculous Mycobacterial Infection.In vitro activity of amikacin against isolates of Mycobacterium avium complex with proposed MIC breakpoints and finding of a 16S rRNA gene mutation in treated isolates.Inhaled amikacin for treatment of refractory pulmonary nontuberculous mycobacterial disease.Consensus summary of aerosolized antimicrobial agents: application of guideline criteria. Insights from the Society of Infectious Diseases Pharmacists.Inhaled liposomal amikacin.Antibiotic treatment for nontuberculous mycobacterial lung disease.Time-kill kinetics of slowly growing mycobacteria common in pulmonary disease.Treatment of Non-Tuberculous Mycobacterial Lung Disease.The efficacy, safety, and feasibility of inhaled amikacin for the treatment of difficult-to-treat non-tuberculous mycobacterial lung diseases.Aerosolized amikacin in patients with difficult-to-treat pulmonary nontuberculous mycobacteriosis.Nontuberculous mycobacteria in cystic fibrosis: Updates and the path forward.Amikacin: Uses, Resistance, and Prospects for Inhibition.
P2860
Q26775974-2B54DA38-A4EB-4E1D-9BFF-FDE765C4D268Q33792765-E44FA526-1C03-4398-AE37-DF82C5F00F7AQ34167455-1D5921DA-304E-43A5-BEDA-EBD3FBDA8FC2Q34402665-78E10E3A-7511-4BFA-9D5B-8781994B3724Q35925366-EE3AFA38-E0A9-4083-81AF-3BD6A0AD11ABQ36099490-101AD432-B815-40F7-AC9B-31FBFEF5FB7AQ36567746-9B5A4891-4988-4366-9DC5-E05C72C387A7Q37264308-6FD8E256-779A-4D3B-BBF9-E98C1E1DF47BQ37679776-D6674B1A-97EF-499E-A694-10AABD54342AQ37760514-906ED8AA-C487-4732-B785-F320A2AD44EAQ38216555-5BD00E12-9BE8-4DD5-9F16-1F1738D1ACE1Q38770072-8517017A-79FB-4FE3-993A-8CC4D8216E9FQ38988324-545BF2DC-F5DE-4FE9-AB41-17CC343FF100Q39321216-91EB1C6B-10FD-4D34-9E8D-03E44CC42904Q40100000-7D3FF552-2197-4481-BA77-D62DB42441F1Q43536267-AA0862BD-4611-4AE3-9B8C-6F351708FF7BQ47960948-0D1C8B3D-5510-492A-BEC9-2A1CACAA7CD4Q52744431-A95B793B-FB6A-45B2-840A-7D827B60A8AB
P2860
Aerosolized amikacin for treatment of pulmonary Mycobacterium avium infections: an observational case series.
description
2007 nî lūn-bûn
@nan
2007 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Aerosolized amikacin for treat ...... an observational case series.
@ast
Aerosolized amikacin for treat ...... an observational case series.
@en
type
label
Aerosolized amikacin for treat ...... an observational case series.
@ast
Aerosolized amikacin for treat ...... an observational case series.
@en
prefLabel
Aerosolized amikacin for treat ...... an observational case series.
@ast
Aerosolized amikacin for treat ...... an observational case series.
@en
P2093
P2860
P356
P1476
Aerosolized amikacin for treat ...... an observational case series.
@en
P2093
Kala K Davis
Peter N Kao
Stephen J Ruoss
Susan S Jacobs
P2860
P2888
P356
10.1186/1471-2466-7-2
P577
2007-02-23T00:00:00Z
P5875
P6179
1031417829